(lp0
S"Two little numbers and one big number are key for Exelixis' future. Motley Fool - Mar 14, 2017 Exelixis  boasts several numbers that make its shareholders smile. The biotech's stock has soared more than 430% over the past 12 months."
p1
aS'3 Factors That Drove Exelixis, Inc. Higher By 19% in February Motley Fool - Mar 7, 2017 Shares of Exelixis , a biopharmaceutical company focused on the development of medicines for the treatment of cancer, surged 19% in February, according to data from S&amp;P Global Market Intelligence.'
p2
aS"Exelixis, Inc. Turns a Profit, but Don't Get Too Excited Motley Fool - Mar 1, 2017 Exelixis  reported fourth-quarter earnings on Monday showing solid growth in sales of Cabometyx. The biotech reported a profit for the quarter, but there were some extenuating circumstances that helped push Exelixis into the black.Company Update : Exelixis, Inc. Announces Clinical Trial ... - Smarter AnalystExelixis Announces Webcasts of Investor Conference Presentations in March - Yahoo Finance"
p3
aS"The Case for and Against Exelixis, Inc.  StockNewsJournal - 15 hours ago Exelixis, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $21.74, down from yesterday's close by -0.50%.Insider Trading Activity Exelixis, Inc.   Director Sold 10000 ... - Market ExclusiveExelixis, Inc.  Director Vincent T. Marchesi Sells 40000 Shares - Chaffey Breeze"
p4
aS"Equity Perception: Analyst's Indicator Review for Cousins Properties ... The USA Commerce - 19 hours ago Shares of Cousins Properties Incorporated  dropped -1.00% to $7.94. During the trading on 03/14/2017, Company's stock ranged from $7.87 to $8.02.How much upside really exists in Cousins Properties Incorporated  and ... - USA Commerce DailyAnalysts Stance on 2 Companies: Cousins Properties Incorporated (NYSE:CUZ ... - The Voice Registrar"
p5
aS'Stock Returns: Exelixis Inc  is Beating Agios Pharmaceuticals Inc ... CML News - 19 hours ago This is a snapshot to compare the stock returns for Agios Pharmaceuticals Inc  versus Exelixis Inc  .'
p6
aS'Exelixis, Inc.  Receives FDA Orphan Drug Designation for the Treatment ... Smarter Analyst - Mar 6, 2017 Exelixis, Inc.  announced that the FDA has granted orphan drug designation to cabozantinib for the treatment of hepatocellular carcinoma .Zacks Investment Research Lowers Exelixis, Inc.  to Hold - Chaffey Breeze'
p7
aS"Sprouts Farmers Market, Inc. , Exelixis, Inc.  Stock Eyes Ahead of ... The USA Commerce - Mar 13, 2017 Shares of Sprouts Farmers Market, Inc.  surged 0.39% to $17.85. During the trading on 03/10/2017, Company's stock ranged from $17.63 to $18.18.Pay Too Much Attention To Two Stock Analyst Ratings: Sprouts Farmers Market ... - The Voice Registrar"
p8
aS"The Charts For Exelixis, Inc.  Is Speaking Volumes Today NY Stock News - 19 hours ago Exelixis, Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p9
aS"Traders Secrets on Exelixis, Inc. , MGIC Investment Corporation  StockNewsJournal - Mar 10, 2017 Investors who are keeping close eye on the stock of Exelixis, Inc.  established that the company was able to keep return on investment at -23.14 in the trailing twelve month while Reuters data showed that industry's average stands at -3.48&nbsp;..."
p10
a.